Project Number 5K01NS096719-03 Agency/Funding Organization NINDS Funding Year 2018 View Full Project Details for Advancing Antibody Technology for tau Immunotherapies and for Investigating tau Pathogenesis Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Category F. Research Resources 3. Professional and Career Development c. Career Development Researcher and Organization Principal Investigator GALLARDO, GILBERT Principal Investigator First Name GILBERT Principal Investigator Last Name GALLARDO Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-257: NINDS FACULTY DEVELOPMENT AWARD TO PROMOTE DIVERSITY IN NEUROSCIENCE RESEARCH (K01) FY Overall Cost $218,502 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CORRIVEAU, RODERICK A Related Resources Repository [AlzPED] AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy.
